Edition:
India

Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

6.68USD
12:27am IST
Change (% chg)

$0.21 (+3.25%)
Prev Close
$6.47
Open
$6.46
Day's High
$6.68
Day's Low
$6.45
Volume
12,457
Avg. Vol
50,209
52-wk High
$12.04
52-wk Low
$5.35

Chart for

About

Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company's segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to... (more)

Overall

Beta: 0.85
Market Cap(Mil.): $485.96
Shares Outstanding(Mil.): 46.55
Dividend: --
Yield (%): --

Financials

BRIEF-Enzo Biochem Says Patent Trial And Appeal Board Has Denied A Petition Filed By Hologic For Inter Partes Review

* ENZO BIOCHEM INC - PATENT TRIAL AND APPEAL BOARD HAS DENIED A PETITION FILED BY HOLOGIC FOR INTER PARTES REVIEW Source text for Eikon: Further company coverage:

24 Apr 2018

BRIEF-Enzo Biochem Reports Q2 Adjusted Loss Per Share $0.04

* QTRLY LOSS PER SHARE $0.02 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

13 Mar 2018

BRIEF-Austock Group ‍Says Enzo Silverii Retires As Chief Financial Officer​

* GORDON JOSEPH WILL BE ACTING CFO Source text for Eikon: Further company coverage:

27 Feb 2018

BRIEF-Enzo Biochem Q1 Non-GAAP Loss Per Share $0.01

* Q1 REVENUE $27.7 MILLION VERSUS $26.3 MILLION Source text for Eikon: Further company coverage:

08 Dec 2017

Earnings vs. Estimates